Effect of a Probiotic Supplement on Gut Microbiota and Glycemic Control in Patients With Type 1 Diabetes (PRODIAB)

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Diabete Type 1
Interventions
DIETARY_SUPPLEMENT

Probiotic/Prebiotic Supplement

Oral dietary supplement in gel form (10 mL per day) containing 4000 mg of inulin and 1000 mg of tyndallized probiotics. Administered once daily for approximately 98 consecutive days. Produced by Martínez Nieto S.A. (MARNYS®). Intended to modulate gut microbiota and improve glycemic and inflammatory markers.

DIETARY_SUPPLEMENT

Placebo Gel

Oral placebo in gel form (10 mL per day), identical in appearance, texture, and taste to the active supplement, but without probiotic or prebiotic components. Administered once daily for 98 days to maintain blinding and control effects.

Trial Locations (1)

30107

UCAM San Antonio Catholic University of Murcia, Murcia

All Listed Sponsors
lead

Universidad Católica San Antonio de Murcia

OTHER

NCT07062224 - Effect of a Probiotic Supplement on Gut Microbiota and Glycemic Control in Patients With Type 1 Diabetes (PRODIAB) | Biotech Hunter | Biotech Hunter